SG Americas Securities, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$34
-82.8%
31,493
-79.0%
0.00%
-100.0%
Q1 2023$198
-99.8%
149,771
+46.8%
0.00%
+100.0%
Q3 2022$120,000
-46.4%
102,058
-48.5%
0.00%
-50.0%
Q2 2022$224,000
+187.2%
198,210
+576.3%
0.00%
Q4 2021$78,000
-73.9%
29,307
-64.4%
0.00%
-100.0%
Q3 2021$299,000
+443.6%
82,275
+545.0%
0.00%
Q2 2021$55,000
-57.4%
12,756
-66.3%
0.00%
-100.0%
Q1 2021$129,000
-91.6%
37,810
-91.3%
0.00%
-87.5%
Q4 2020$1,528,000
+730.4%
436,450
+469.9%
0.01%
+700.0%
Q3 2020$184,000
+776.2%
76,579
+564.4%
0.00%
Q2 2020$21,000
-90.5%
11,526
-91.8%
0.00%
-100.0%
Q1 2020$220,000
+368.1%
141,165
+540.0%
0.00%
Q4 2019$47,000
+23.7%
22,056
+9.4%
0.00%
Q3 2019$38,000
-30.9%
20,160
-6.2%
0.00%
-100.0%
Q1 2019$55,000
-37.5%
21,482
-31.3%
0.00%0.0%
Q2 2018$88,000
+41.9%
31,262
+79.8%
0.00%
Q1 2018$62,000
+12.7%
17,388
+21.7%
0.00%
-100.0%
Q4 2017$55,000
-63.6%
14,283
-76.0%
0.00%0.0%
Q3 2017$151,000
+387.1%
59,401
+415.2%
0.00%
Q2 2017$31,000
-29.5%
11,529
-13.9%
0.00%
Q1 2017$44,000
-51.6%
13,398
-65.0%
0.00%
-100.0%
Q4 2016$91,000
+65.5%
38,257
+45.6%
0.00%
Q1 2016$55,000
-16.7%
26,280
+21.5%
0.00%
Q4 2015$66,000
-2.9%
21,635
-38.6%
0.00%
Q3 2014$68,000
+21.4%
35,221
+126.2%
0.00%
Q3 2013$56,00015,5740.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders